Antengene. Corp.
Shanghai, Shanghai, China
Vice President of Drug Discovery and Translational Medicine at Antengene Corporation, holds a Ph.D. in Biomedical Sciences from the University of Leeds, UK. He has published multiple high-impact research papers as the first author or corresponding author in prestigious journals including Nature, Science Advances, and Cancer Research. With nearly forty patent applications filed for novel drug discoveries, he has driven the advancement of multiple innovative therapeutics into clinical development stages as an inventor or key contributor, spanning monoclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), and small molecule drugs.
Sunday, October 26, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): Antengene: Employee (Ongoing), Intellectual Property/Patents (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)
